Grifols, S.A. American Depositary Receipt (GRFS)
NASDAQ
Real-time Data
01:30 PM
Day's Range
7.9452 wk Range
6.96Overview - GRFS - Grifols, S.A. American Depositary Receipt
Key Statistics
Valuation
Enterprise Value
25.85B
P/E (Trailing)
‪10.38‬
P/E (Forward)
‪5.61‬
PEG Ratio
‪0.06‬
Price / Sales (TTM)
‪0.73‬
Price / Book
‪1.68‬
EV / EBITDA
‪13.45‬
Profitability
Gross Margin
‪37.62%‬
Profit Margin
‪6.09%‬
Operating Margin
‪15.90%‬
Return on Assets
‪4.23%‬
Return on Equity
‪6.93%‬
Ownership
Shares Outstanding
680.58M
Float
836.24M
Held by Insiders
‪0.00%‬
Held by Institutions
‪57.17%‬
Price stats
Beta
‪1.19‬
50-Day Avg
‪7.60‬
200-Day Avg
‪8.32‬
Dividends
Payout Ratio
‪36.83%‬
Frequency
Annual
Analyst Consensus
2 analysts
Average price target
‪$ 10.87‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GRFS - Grifols, S.A. American Depositary Receipt
Peers - GRFS - Grifols, S.A. American Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- GRFSNASDAQGrifols, S.A. American Depositary Receipt5.44BMarket Cap-22.75%52-week change10.39P/E (Trailing)‪6.09%‬Profit Margin
- AZNNASDAQAstraZeneca PLC American Depositary Shares258.54BMarket Cap+4.43%52-week change24.88P/E (Trailing)‪17.02%‬Profit Margin
- AMGNNASDAQAmgen Inc.239.95BMarket Cap+34.76%52-week change27.32P/E (Trailing)‪22.95%‬Profit Margin
- GILDNASDAQGilead Sciences Inc.181.95BMarket Cap+22.21%52-week change17.87P/E (Trailing)‪-10.63%‬Profit Margin
- SNYNASDAQSanofi American Depositary Receipt109.47BMarket Cap-9.72%52-week change24.26P/E (Trailing)‪8.09%‬Profit Margin
- ROPNASDAQRoper Technologies Inc.41.09BMarket Cap-26.22%52-week change17.15P/E (Trailing)‪30.24%‬Profit Margin
- BIIBNASDAQBiogen Inc.32.22BMarket Cap+37.32%52-week change38.44P/E (Trailing)‪8.32%‬Profit Margin
Profile Summary - GRFS - Grifols, S.A. American Depositary Receipt
About
Grifols S.A. is a Spanish multinational pharmaceutical and chemical manufacturer that operates internationally, focusing on innovative solutions in the health sector. The company is known for specializing in the production of plasma-derived medicines, transfusion medicine, and clinical diagnostics. Through its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
